Market Update by Liontrust – Q2 2022

Liontrust GF High Yield Bond Fund is manufactured by Liontrust Fund Partners LLP and represented in Malta by MeDirect Bank (Malta) plc.

Market review

This has probably been the most challenging quarter of my fund management career for both the strategy and the market. While government bond markets had the worst first half to a year since the 1850’s and major equity aggregates the worst since 1970, liquidity and market moves point to stress that has arguably not been seen in credit markets since the global financial crisis.

Fundamentally, we view the market as temporarily broken, but do not think the same is true of the business models of the companies we lend to. We believe patience will be rewarded with strong returns from this point and Phil and I remain heavily invested in the Fund alongside you.

In the second quarter, close to 60% of the index-relative underperformance has come from bonds in the real estate sector. We believe this sector is suffering particularly because of troubled debt capital markets, not broken business models. That is certainly our view of the companies that we lend to on your behalf.

Frustratingly, given the marked underperformance, there has been zero bad news in relation to the Fund’s holdings during the period. Other unrelated real estate companies, Adler and SBB, have had very aggressive notes written by the fearsome short-selling fund, Viceroy, with accusations of financial shenanigans the key issue. Add to this some sentiment spill-over from everything happening in Chinese real estate (which is mainly a property development issue) add bid side liquidity in real estate bonds has gone very dry.

Fund review

Over the quarter, the Liontrust GF High Yield Bond Fund (A1, accumulation class, total return in euros) produced a return of -8.9% versus the ICE BAML Global High Yield index’s (euro hedged) -7.0%*.

Anecdotally, there has been forced selling due to industry-wide outflows and hedge funds have taken the opportunity to attack the whole sector in Europe. The drop in prices has been dramatic. To put it into context, our holding in bonds issued by Swedish office company, Castellum has dropped in value by around 45% since the end of March, while the high yield market has returned about -10% during the period. Our holding in Heimstaden, a residential real estate company, has fallen -36%. Our holding in CPI Property, a CEE/German primarily office company, has fallen -35%. Even in the last week of the quarter, the Castellum bond fell by 12pts into month end, but then as I type on 1st July, has bounced ~10pts and is bid by various counterparts. This is evidence of market technical at play, not fundamentals.

Note the diversity we have between residential and office, which have much different elasticities of demand, and also by geography across Nordics and Germany/Central Eastern Europe (N.B., not Russia and Ukraine). In addition, please note that in each case, the parent company of the bond issuer is an investment grade-rated company and the minimum rating amongst the three bonds is BB-. The Nordic economies have low debt-to-GDP ratios in an international context and very healthy banks. These companies are mainly landlords, not property developers.

Moreover, the loan-to-value of each company is below 50% and the companies generate profit which far outweighs interest cost. Indeed, each company has tenant agreement based on index pricing, so rents will continue to increase in this inflationary environment. We continue to believe each of these companies are resilient and sustainable.

However, we have to concede that the deterioration in sentiment towards European real estate companies has taken us by surprise. We have felt low LTVs and high interest coverage ratios would provide resilience, which we believe will still prove to be true, but the market, at least the European debt capital market, is testing this view.

Indeed, the market is treating these bonds like its 2008/9. The fundamentals in the property sector, although coming off a top, do not match that level of bearishness, in our view. The bonds in question do have flexibility over when they redeem, which impacts the present value, but we believe each company will remain a going concern.

This appears also to be the view of the equity market for the two listed companies. For example, Castellum’s market cap is SEK46bn, versus around SEK150bn of property assets and ~SEK77bn of debt. Heimstaden and CPI Property have told us they are considering buying their own bonds at stressed prices and also that they fully intend to call bonds (at par) at first call dates. Using the Castellum bond, should they choose not to call at any date (not our base case), the current spread into perpetuity is in excess of 8%.

In recent conversations with Castellum’s Head of Treasury, he confirmed that the Swedish banks continue to support his company and the spreads at which they lend to them are the same today as last year, five years, ten years ago.

Heimstaden recently confirmed to us SEK40bn of liquidity, which can cover debt maturities to 2025, assuming debt capital markets remain closed.

CPI Property has continued to issue debt in Germany and US during this difficult quarter. It has a bank loan that was issued to bridge finance of its recent acquisition of a competitor, which falls due in 2024. Excluding this bridge finance, which the company has used the recent debt issuance to partially repay, the weighted average life of its debt is 5.3 years and it has no debt to refinance in European debt capital markets until 2026. The company also has €2.4bn of liquidity, which is approximate to the amount of debt that matures in the next two years. Meanwhile, all of these companies are cash flow generative.

Away from real estate, bonds issued by pharmaceutical company Bausch Health cost the fund ~35bps relative to index. Bausch Health is spinning off a relatively stable part of the business (Bausch & Lomb eyecare) and leaving the remaining pharmaceutical business with a lot of debt to deal with. Meanwhile, a competitor is challenging the patent on one of its key drugs, a major driver of revenue. This was all known before March, but the drop in sentiment has seen the market really punish companies with some uncertainty. We believe Bausch has enough time (no major debt to deal with before 2025) and cash flow potential (could generate $4.5bn cash in next 2-3 years) to get through this tricky period. We have reduced the position size at an average price of 77 (current price 55), but remain with a ~1% position.

Another detractor, automated transaction machine manufacturer Diebold, had a profit warning largely based on supply chain bottlenecks. It has a lot of debt to deal with 2023-2025 and the issues it is having in 2022 make refinancing trickier. It plans to issue asset-backed financing to refinance the bank debt which falls due next year. It is allowed to issue this ahead of the secured bonds (which we owned) and ahead of the bank debt it will replace. We are left uncomfortable that secured bonds will be junior to the new debt and this is before we consider the prospect of recession in 2022/23. We sold the bonds at 76.5, which was a relative hit to funds in the region of 27bps.

More positively, during the quarter it was announced that the large European recruitment agency House of HR is being acquired by private equity, and it will seek to refinance the bonds in the bank market at some point in Q3. This held the House of HR bonds close to par in a falling market.

Outlook

There is plenty in the world to worry about, but we don’t believe there is a material risk of a systemic rise in default rates. Of course, in a world of both higher interest rates and energy prices, profits and cash flow will be squeezed, but we believe there is enough quality and resilience in the high yield market to continue to make good risk-adjusted returns in this type of environment. This applies to BB-rated and B-rated bonds although, spoiler alert, we don’t think this is the case in CCC-rated bonds!

US high yield spreads are still below the long-term average, but with the number of interest rate hikes priced into US government bonds, the overall yield is in line with the long-term average. Given the likely resilience the US economy has to continued conflict in Europe, we think US high yield is decent value.

However, with European spreads above the long-term average, we also like valuations in Europe. The Fund is split fairly evenly between US and Europe (including the UK), which in an index context represents a large European overweight. The Fund has light exposure to cyclicals and companies with high energy costs of production. We have zero airlines, which are so exposed to fuel costs. The quality bias we have within our process means we are light in CCC-rated risk, which is only 5% of Fund. Moreover, our quality bias means we seek companies with pricing power and resilience, two operational qualities that are the best defence in more difficult economic periods.


Liontrust Key risks & Disclaimers:

Past performance is not a guide to future performance. Do remember that the value of an investment and the income generated from them can fall as well as rise and is not guaranteed, therefore, you may not get back the amount originally invested and potentially risk total loss of capital. The issue of units/shares in Liontrust Funds may be subject to an initial charge, which will have an impact on the realisable value of the investment, particularly in the short term. Investments should always be considered as long term.

Investment in the GF High Yield Bond Fund involves foreign currencies and may be subject to fluctuations in value due to movements in exchange rates. The value of fixed income securities will fall if the issuer is unable to repay its debt or has its credit rating reduced. Generally, the higher the perceived credit risk of the issuer, the higher the rate of interest. Bond markets may be subject to reduced liquidity. The Fund may invest in emerging markets/soft currencies and in financial derivative instruments, both of which may have the effect of increasing volatility.

Issued by Liontrust Fund Partners LLP (2 Savoy Court, London WC2R 0EZ), authorised and regulated in the UK by the Financial Conduct Authority (FRN 518165) to undertake regulated investment business.

This document should not be construed as advice for investment in any product or security mentioned, an offer to buy or sell units/shares of Funds mentioned, or a solicitation to purchase securities in any company or investment product. Examples of stocks are provided for general information only to demonstrate our investment philosophy. It contains information and analysis that is believed to be accurate at the time of publication, but is subject to change without notice. Whilst care has been taken in compiling the content of this document, no representation or warranty, express or implied, is made by Liontrust as to its accuracy or completeness, including for external sources (which may have been used) which have not been verified. It should not be copied, faxed, reproduced, divulged or distributed, in whole or in part, without the express written consent of Liontrust. Always research your own investments and (if you are not a professional or a financial adviser) consult suitability with a regulated financial adviser before investing.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from Liontrust Fund Partners LLP. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest should always be based upon the details contained in the Prospectus and Key Investor Information Document (KIID), which may be obtained from MeDirect Bank (Malta) plc.

Franklin Templeton thoughts: Emerging markets are down, but not out

Global markets are facing a number of headwinds this year, but there are also reasons for optimism, according to Franklin Templeton Emerging Markets Equity CIO Manraj Sekhon. He shares his mid-year outlook for emerging markets.

The inflation genie is out of the bottle and is a multi-layered challenge for policymakers. Rising energy, food and wage costs are combining to raise inflation expectations, which if left unchecked could destabilize the global economy.

Our base case for emerging markets (EM) is built on the reality they entered this current downturn in better health than prior cycles. Corporate leverage is lower, financial sector and other reforms have been implemented, and most policymakers are pursuing orthodox monetary and fiscal policies to address challenges. Nonetheless, we acknowledge the range and probability of alternative scenarios has increased.

Earnings picture

In contrast to some other market observers expecting a contraction in EM earnings in 2023, at the start of this year we highlighted the likelihood of a recovery driven by India and China. China’s flexible policy response and India’s resilient gross domestic product outlook mean a recovery remains our base case.  

China’s transition to a dynamic zero-COVID policy signals an easing of some, but not all, the risks associated with its management of the virus. Factories are reopening, port bottlenecks are easing, and there are signs that supply chain disruptions are diminishing. We expect China’s stance in managing the virus to remain in place through the 20th Party Congress in the fall, where China’s President Xi Jinping’s position is expected to be confirmed for a third term. 

Inflation challenge

EM inflation, driven by rising energy, food and wage costs, has created challenges for policymakers. In the past, subsidies have been used to limit the squeeze on incomes from rising prices of necessities. In the current cycle, direct transfers are the preferred policy tool. The full effect of higher inflation will take time to filter through EMs, with significant consequences for lower-income households if left unchecked.

There are similarities between the rise in inflation in 2008 and today. Oil prices peaked at US $145 in July 2008, pushing transport and fertilizer prices higher, which combined with supply challenges to increase global food prices. This had a greater effect on EM relative to developed market (DM) inflation due to the higher weight of food in the EM inflation basket.

Rising oil prices are once again pushing up transport and fertilizer prices, and war is disrupting the supply of grain and oil seeds from Ukraine. Policymakers in Asia are responding with export bans in Malaysia, Indonesia and India, and there are discussions about the formation of a de-facto rice export cartel in Thailand and Vietnam.

Similar measures were ineffective in 2008 and are unlikely to work in 2022 (Indonesia has already rolled back its palm oil export ban). Grain stocks in storage are high, but the challenge is much of this is trapped in Ukraine. This puts the focus on policymakers to find a solution to prevent the global food- price shock to follow the energy-price shock.

New realities

EM central banks moved to raise interest rates ahead of their DM peers to address price pressures stemming from excess demand. The Brazilian central bank first raised the Selic target rate in March 2021. India, Poland and other EMs have followed suit with rate hikes. Chinese policymakers were also prudent in curbing excess demand early, creating room for policy easing to stimulate growth now.

EM equity market valuations have declined in line with a correction in global markets. New-economy sectors, including technology and communication services, have led the retreat. Conversely, traditional sectors, including financials and industrials, have witnessed relative outperformance.1

Investors’ flight to safety away from EMs toward the relative safety of US dollar-based assets is a phenomenon we have witnessed in prior cycles. Nevertheless, markets have recognized the new reality, as reflected in the unusually low level of volatility in EM currencies relative to DM, and EM equity market outperformance relative to DM in 2022.2


Endnotes:

1.Sources: MSCI, Bloomberg. Performance period is February 17, 2021 – June 14, 2022. Past performance is not an indicator or a guarantee of future results.

2. Sources: MSCI, Bloomberg, As of June 17, 2022. Emerging markets represented by the MSCI Emerging Markets Index, which captures large- and mid-cap representation across 24 emerging-market countries. Developed markets represented by the MSCI World Index, which captures large- and mid-cap performance across 23 developed markets. Indexes are unmanaged and one cannot directly invest in them. They do not include fees, expenses or sales charges. Past performance is not an indicator or guarantee of future results. MSCI makes no warranties and shall have no liability with respect to any MSCI data reproduced herein. No further redistribution or use is permitted. This report is not prepared or endorsed by MSCI. Important data provider notices and terms available at www.franklintempletondatasources.com.


Franklin Templeton Disclaimer:

Important legal Notice

This material is intended to be of general interest only and should not be construed as individual investment advice or a recommendation or solicitation to buy, sell or hold any security or to adopt any investment strategy. It does not constitute legal or tax advice. This material may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

The views expressed are those of the investment manager and the comments, opinions and analyses are rendered as at publication date and may change without notice. The underlying assumptions and these views are subject to change based on market and other conditions and may differ from other portfolio managers or of the firm as a whole. The information provided in this material is not intended as a complete analysis of every material fact regarding any country, region or market. There is no assurance that any prediction, projection or forecast on the economy, stock market, bond market or the economic trends of the markets will be realized. The value of investments and the income from them can go down as well as up and you may not get back the full amount that you invested. Past performance is not necessarily indicative nor a guarantee of future performance. All investments involve risks, including possible loss of principal.

Any research and analysis contained in this material has been procured by Franklin Templeton for its own purposes and may be acted upon in that connection and, as such, is provided to you incidentally. Data from third party sources may have been used in the preparation of this material and Franklin Templeton (“FT”) has not independently verified, validated or audited such data.  Although information has been obtained from sources that Franklin Templeton believes to be reliable, no guarantee can be given as to its accuracy and such information may be incomplete or condensed and may be subject to change at any time without notice. The mention of any individual securities should neither constitute nor be construed as a recommendation to purchase, hold or sell any securities, and the information provided regarding such individual securities (if any) is not a sufficient basis upon which to make an investment decision. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments, opinions and analyses in the material is at the sole discretion of the user.

Products, services and information may not be available in all jurisdictions and are offered outside the U.S. by other FT affiliates and/or their distributors as local laws and regulation permits. Please consult your own financial professional or Franklin Templeton institutional contact for further information on availability of products and services in your jurisdiction.

Issued in the U.S. by Franklin Distributors, LLC, One Franklin Parkway, San Mateo, California 94403-1906, (800) DIAL BEN/342-5236, franklintempleton.com – Franklin Distributors, LLC, member FINRA/SIPC, is the principal distributor of Franklin Templeton U.S. registered products, which are not FDIC insured; may lose value; and are not bank guaranteed and are available only in jurisdictions where an offer or solicitation of such products is permitted under applicable laws and regulation.

 CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.

WHAT ARE THE RISKS?

All investments involve risks, including the possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested. Investments in foreign securities involve special risks including currency fluctuations, economic instability and political developments. Investments in emerging markets, of which frontier markets are a subset, involve heightened risks related to the same factors, in addition to those associated with these markets’ smaller size, lesser liquidity and lack of established legal, political, business and social frameworks to support securities markets. Because these frameworks are typically even less developed in frontier markets, as well as various factors including the increased potential for extreme price volatility, illiquidity, trade barriers and exchange controls, the risks associated with emerging markets are magnified in frontier markets. To the extent a strategy focuses on particular countries, regions, industries, sectors or types of investment from time to time, it may be subject to greater risks of adverse developments in such areas of focus than a strategy that invests in a wider variety of countries, regions, industries, sectors or investments. China may be subject to considerable degrees of economic, political and social instability. Investments in securities of Chinese issuers involve risks that are specific to China, including certain legal, regulatory, political and economic risks.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from Franklin Templeton Investment Management Limited (FTIML). No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Investor Information Document (KIID), which may be obtained from MeDirect Bank (Malta) plc.

Liontrust Insights: The Multi-Asset Process

By John Husselbee, Head of the Liontrust Multi-Asset Investment Team.

Key Points:

  • Volatility expected to continue through summer, with central bank activity depending on inflation
  • Rising fears around stagflation, with UK predicted to suffer a tough 2023
  • More opportunities emerging for active managers to add value post-indiscriminate selling

As expected, central banks lived up to their name and played a central role over June, dictating sentiment in another volatile month during which markets dipped into bear territory again before rallying in the final week.

In the days leading up to the June Federal Reserve meeting, a 75 basis point (bps) interest rate hike – the largest since 1994 – was well trailed and had been fully priced in by the time chair Jay Powell made the announcement. With hiking so widely anticipated at present, focus tends to move very swiftly from the rise in question to the timing and scope of the next one and when we might potentially see the much-desired peak hawkishness. At his press conference, Powell acknowledged this latest hike was unusually large and he is not expecting such moves to be common, but also confirmed something similar for July unless price rises soften. The dot plot has shifted to suggest aggressive tightening is likely to continue for the next few meetings and also revealed officials to be unanimous in thinking the rate needs to get above estimates of neutral by year end.

Highlighting the Fed’s sink-throwing mindset, downward revisions to growth and employment in the latest Summary of Economic Projections (SEP) showed policymakers admitting their actions will likely have a detrimental impact on both. ‘We never seek to put people out of work,’ Powell said, ‘but you really cannot have the kind of labour market we want without price stability.’ He also acknowledged the task of engineering a soft economic landing is ‘very challenging’ in testimony to the Senate.

Thus far, economic growth certainly appears to be moderating but an inflection point in inflation is yet to follow. As a small point to keep in the back of people’s minds, the last time the Fed pushed through a 75bps rise, in November 1994, it was back in rate cutting mode just seven months later.

Despite fears this action from the Fed might spook other central banks, the Bank of England continued its early and steady approach, with a fourth consecutive 0.25% rise. Consensus is no longer as solid as it was, however, with three of nine members of the Bank’s Monetary Policy Committee voting for 50bps. Again, this latest hike was fully priced in after inflation hit 9% in April, with the level expected to climb above 11% by October.

Elsewhere, the European Central Bank cast off any lingering dovishness over the month and prepared the market for its own hiking cycle to begin in July. Following the path laid by the Fed, the ECB has not committed to 25 basis point increments beyond July and a 0.50% rise is now the base case for September, with inflation unlikely to moderate before then. Another Bank seeing the need to move into whatever it takes territory, the ECB has not provided guidance on the ultimate rate ceiling or neutral level and plans to hike until medium-term inflation stabilises around its target.

To give a couple of noteworthy, and opposing, last stops on our central bank world tour, June saw the Swiss National Bank fall into line with a hike, its first in 15 years, whereas the Bank of Japan has maintained its position as an increasingly isolated dove by sticking to ultra-loose monetary policy. Despite sharp falls in the yen, the BoJ said it will continue its programme of buying huge amounts of government bonds and expects to keep short-term interest rates at current or lower levels (currently -0.1%).

Against this backdrop, sentiment and macro consensus are clearly starting to turn more bearish, with a record net 73% of investors expecting the global economy to weaken over the coming year and stagflation fears at their highest since 2008, according to the latest Bank of America fund manager survey. Investors are particularly negative on Europe, with 54% predicting recession over the next year, up from 28% in May, while 83% expect above-trend inflation and below-trend growth over the coming 12 months.

Meanwhile, work from the World Bank has compared the current state of the global economy with the stagflation-blighted 1970s. Predictions from its economists suggest the slowdown in growth between 2021 and 2024 is on course to be twice that of the period between 1976 and 1979.

To highlight the parallel, recovery from the high inflation that followed the oil shocks of the mid to late-1970s required steep increases in interest rates, which played a prominent role in triggering a string of financial crises in the early part of the subsequent decade. That period of stagflation was also sparked by persistent supply-side disturbances fuelling inflation, preceded by highly accommodative monetary policy in major advanced economies. In terms of differences, the dollar is stronger today, the percentage increases in commodity prices are smaller, and the balance sheets of financial institutions are generally much healthier. More importantly, central banks in advanced and many developing economies now have clear mandates for price stability, and, over the past three decades, have established a track record of achieving inflation targets.

The World Bank said subdued growth is likely to persist throughout the 2020s because of weak investment in most of the world and even if a global recession is averted, the pain of stagflation could persist for several years – unless major supply increases are set in motion. Against this backdrop, the UK looks set to be a particular lowlight: OECD figures suggest GDP is expected to stagnate in 2023 amid persistent supply chain shortages and rising inflation, with only Russia in worse shape in the G20.

One thing to consider in this increasingly pervasive gloom, however, is that the idea of a ‘global’ slowdown only goes so far: in reality, the three largest economic blocs – the US, eurozone and China – face very different challenges in nature and scope, which will have implications for both any downturn and subsequent recovery.

Taking the US first, activity has actually remained fairly solid over recent months, in contrast to financial market turmoil, and while higher rates are expected to put the brakes on growth over the second half of the year, many economists are predicting the slowdown will be confined to the most rate-sensitive parts of the economy. As would be expected, President Biden is continuing to say recession is not certain but a number of chief executives are starting to bow to the inevitable with job cuts: Tesla is reducing its salaried workforce by roughly 10% over the next three months or so, for example, with Elon Musk admitting the company grew too fast in some areas, while JPMorgan’s Jamie Dimon has warned a hurricane is coming our way.

While the US is expected to benefit via its relative energy self-sufficiency, the eurozone, meanwhile, has far deeper ties to Russia and remains a large net importer of energy, and has therefore suffered a far more severe deterioration in its terms of trade as global energy prices surged. As outlined earlier, this situation has forced the ECB to move to a more hawkish stance and policymakers are wrestling with the questions that have been perplexing other central bankers: whether to support the real economy or rein in inflation.

Finally, China is facing a more complex set of problems, grappling with a zero-Covid policy as well as a range of more cyclical hurdles: the country’s recovery from the first wave of Covid was aided by a surge in construction but debt issues crippling many of the property giants have left them struggling to finance projects. While activity may rebound as the government gets on top of Omicron and lockdowns are lifted, and recently announced support measures come into effect, longer-term recovery could be more muted.

What all this suggests is that the coming decade is likely to be very different from the last one in terms of sources of investment risk and return.

Shorter term, with stocks having derated so far, pricing in aggressive policy tightening, we see a buying opportunity in markets. UK equities remain cheap and even the S&P 500, long the poster child of overpriced tech giants, is trading slightly below its 10-year average after recent selling, at around 16 times forward earnings.

Talk about bear markets is becoming increasingly frantic but there are a few things to contemplate: we may already be more than halfway through the decline (which tend to last nine to 12 months) and while the average peak to trough of 30% to 40% suggests more room to fall for the S&P 500, for example, most bear periods also include sharp short-term reversals so attempting to move in and out is as ill-advised as ever.

Given the key role of central banks and their focus on – hopefully softening – inflation figures to direct policy, the summer months and beyond are likely to be volatile. Our view is that post-corrections, markets should move beyond indiscriminate selling and focus more on what the earnings cycle is actually telling us. And this is typically an environment where our favoured active managers can prove their worth in assessing how inflation is affecting companies around the world and which are best placed to thrive.


Liontrust Disclaimer:

This is a marketing communication. Before making an investment, you should read the relevant Prospectus and the Key Investor Information Document (KIID), which provide full product details including investment charges and risks. These documents can be obtained, free of charge, from www.liontrust.co.uk or direct from Liontrust. Always research your own investments. If you are not a professional investor please consult a regulated financial adviser regarding the suitability of such an investment for you and your personal circumstances. 

This should not be construed as advice for investment in any product or security mentioned, an offer to buy or sell units/shares of Funds mentioned, or a solicitation to purchase securities in any company or investment product. Examples of stocks are provided for general information only to demonstrate our investment philosophy. The investment being promoted is for units in a fund, not directly in the underlying assets. It contains information and analysis that is believed to be accurate at the time of publication, but is subject to change without notice. Whilst care has been taken in compiling the content of this document, no representation or warranty, express or implied, is made by Liontrust as to its accuracy or completeness, including for external sources (which may have been used) which have not been verified. It should not be copied, forwarded, reproduced, divulged or otherwise distributed in any form whether by way of fax, email, oral or otherwise, in whole or in part without the express and prior written consent of Liontrust.

Key Risks:

Past performance is not a guide to future performance. The value of an investment and the income generated from it can fall as well as rise and is not guaranteed. You may get back less than you originally invested.

The issue of units/shares in Liontrust Funds may be subject to an initial charge, which will have an impact on the realisable value of the investment, particularly in the short term. Investments should always be considered as long term.

Some of the Funds and Model Portfolios managed by the Multi-Asset Team have exposure to foreign currencies and may be subject to fluctuations in value due to movements in exchange rates. The majority of the Funds and Model Portfolios invest in Fixed Income securities indirectly through collective investment schemes. The value of fixed income securities will fall if the issuer is unable to repay its debt or has its credit rating reduced. Generally, the higher the perceived credit risk of the issuer, the higher the rate of interest. Bond markets may be subject to reduced liquidity. Some Funds may have exposure to property via collective investment schemes. Property funds may be more difficult to value objectively so may be incorrectly priced, and may at times be harder to sell. This could lead to reduced liquidity in the Fund. Some Funds and Model Portfolios also invest in non-mainstream (alternative) assets indirectly through collective investment schemes. During periods of stressed market conditions non-mainstream (alternative) assets may be difficult to sell at a fair price, which may cause prices to fluctuate more sharply.


MeDirect Disclaimer:

This information has been accurately reproduced, as received from Liontrust Fund Partners LLP. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest should always be based upon the details contained in the Prospectus and Key Investor Information Document (KIID), which may be obtained from MeDirect Bank (Malta) plc.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.